Clinical Trial Update: WelChol® With Metformin in Treating Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating WelChol (cholestyramine) in combination with metformin for Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Welchol (colesevelam hydrochloride)
• metformin (metformin)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED